SEC Form 4/A · accession 0001567619-18-001787

AMYRIS, INC. · AMRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Director

Period of report

Aug 17, 2018

Accepted (ET)

Aug 24, 2018 · 5:59 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001365916

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (Right to Buy)^F2,F3,F1	$7.52	Aug 17, 2018	A	4,488,072	A	Feb 17, 2019	May 17, 2020	Common Stock	4,488,072	4,488,072	I
Warrant (Right to Buy)^F2,F3,F1	$7.52	Aug 17, 2018	A	619,749	A	Feb 17, 2019	May 17, 2020	Common Stock	619,749	619,749	I
Warrant (Right to Buy)^F2,F3,F4	$7.52	Aug 20, 2018	A	1,855,706	A	Feb 20, 2019	May 20, 2020	Common Stock	1,855,706	1,855,706	I
Warrant (Right to Buy)^F2,F3,F4	$7.52	Aug 20, 2018	A	256,251	A	Feb 20, 2019	May 20, 2020	Common Stock	256,251	256,251	I

F1Due to an unintentional error, the expiration date for the warrants was incorrectly listed as November 17, 2019 in a Form 4 filed on August 21, 2018 (the "Prior Form 4"). The warrants expire on May 17, 2020.
F2The warrants were issued pursuant to those certain Warrant Exercise Agreements, each dated August 17, 2018, between the Issuer and each of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. in exchange for such holders exercising certain common stock purchase warrants issued on August 3, 2017 for cash and surrendering separate common stock purchase warrants issued on August 3, 2017 for cancellation, as described in the Prior Form 4.
F3The General Partner of the holder is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4Due to an unintentional error, the expiration date for the warrants was incorrectly listed as November 20, 2019 in the Prior Form 4. The warrants expire on May 20, 2020.